Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reversible resistance to apoptosis in cutaneous T cell lymphoma.

Annals of the New York Academy of Sciences - 1 Sept 2001

Meech S J, Edelson R, Walsh P, Norris D A, Duke R C

Abstract excerpt

Mycosis fungoides and its leukemic variant, Sézary syndrome, represent the most common forms of cutaneous T cell lymphomas (CTCL). These disorders are clonal neoplasms characterized by the progressive accumulation of cells that resemble activated/memory CD4+ T cells. Unlike their normal counterparts, these malignant lymphocytes have prolonged life spans and are resistant to dying following treatment with most...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD4-Positive T-Lymphocytes
Share to DNA Damage
Share to Fas Ligand Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphoma, T-Cell, Cutaneous

Share to Membrane Glycoproteins

Share to Receptors, Tumor Necrosis Factor

Share to Skin Neoplasms

Share to Stress, Physiological

Source

Identifiers

PMID: 11594582
DOI: 10.1111/j.1749-6632.2001.tb03710.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reversible resistance to apoptosis in cutaneous T cell lymphoma.PMID 11594582Read ↗

The Fas apoptotic pathway in cutaneous T-cell lymphomas: frequent expression of phenotypes associated with resistance to apoptosis.Semantic proximity Read ↗

Decreased expression of Fas (APO‐1/CD95) on peripheral blood CD4+ T lymphocytes in cutaneous T‐cell lymphomasSemantic proximity Read ↗

Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation.Semantic proximity Read ↗

Expression of apoptosis regulators in cutaneous T‐cell lymphoma (CTCL) cellsSemantic proximity Read ↗

Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin.Semantic proximity Read ↗

The role of immune checkpoint receptors in the malignant phenotype of cutaneous T cell lymphoma.Semantic proximity Read ↗

Oncolytic effect of SARS-CoV-2 in a patient with mycosis fungoides (MF): a case reportSemantic proximity Read ↗

Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation.Semantic proximity Read ↗

Telomerase functions beyond telomere maintenance in primary cutaneous T-cell lymphomaSemantic proximity Read ↗

Th1 Response and Cytotoxicity Genes Are Down-Regulated in Cutaneous T-Cell LymphomaSemantic proximity Read ↗

NRAS mutations in cutaneous T cell lymphoma (CTCL) sensitize tumors towards treatment with the multikinase inhibitor Sorafenib.Semantic proximity Read ↗

Transition of Sézary syndrome into mycosis fungoides after complete clinical and molecular remission under extracorporeal photophoresis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.